Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria
Bepotastine, a second-generation antihistamine for allergic rhinitis and urticaria, is widely used in all age groups but lacks appropriate dosing guidelines for pediatric patients, leading to off-label prescriptions. We conducted this study to propose an optimal dosing regimen for pediatric patients...
Saved in:
Main Authors: | Sukyong Yoon (Author), Byung Hak Jin (Author), Choon Ok Kim (Author), Kyungsoo Park (Author), Min Soo Park (Author), Dongwoo Chae (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population pharmacokinetic‐pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study
by: Yun Seob Jung, et al.
Published: (2024) -
Model-informed precision dosing in vancomycin treatment
by: Sukyong Yoon, et al.
Published: (2023) -
An investigator-blind randomized controlled trial comparing effectiveness, safety of levocetirizine and bepotastine in chronic urticaria
by: Amrita Sil, et al.
Published: (2021) -
A prospective, randomized, open-label, active-controlled study to compare the efficacy and safety of levocetirizine and bepotastine in chronic spontaneous urticaria
by: Gaurav Menghani, et al.
Published: (2023) -
Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
by: Wang XY, et al.
Published: (2016)